The limitations of current chemotherapeutic drugs are still a major issue in cancer treatment.
Thus, targeted multimodal therapeutic approaches need to be strategically developed to …

Drug repurposing is a strategy used to develop new treatments based on approved or
investigational drugs outside the scope of their original clinical indication. Since this …

Cigarette smoking killed about 8 million people every year and promoted non-small cell lung
cancer (NSCLC). We investigated the molecular mechanism of smoking-promoted NSCLC …

Macrophage is an essential part of the tumor immune microenvironment of pancreatic ductal
adenocarcinoma. In our study, we explored the CXCR4+ macrophages subset on its …

Non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, calls for
better therapy. Yi-Fei-San-Jie-pill (YFSJ), a well-applicated traditional Chinese medicine …

Introduction Neuroendocrine transformation (NET) is a resistance mechanism for epidermal
growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors …

Colorectal cancer (CRC) incidence is rising globally. Hence, preventing this disease is a
high priority. With this aim, we determined the CRC prevention potential of the TRAIL …

Lung cancer (LC) is the leading cause of cancer‐related death worldwide, with non‐small
cell lung cancer (NSCLC) comprising 85% of all cases. COX‐2, an enzyme induced …

Lung cancer cells in the tumor microenvironment facilitate immune evasion that leads to
failure of conventional chemotherapies, despite provisionally decided on the genetic …

Both curcumin and naproxen have pain relief activity, making it possible to co-administrate
these drugs in the same prescription. This study aimed to assess the potential …